RecruitingNot ApplicableNCT07123181

Oregano and Basil Leaves and Coronary Artery Disease

Effects of Increasing Polyphenol Intake by Consumption of Oregano and Basil Leaves on Plasma Inflammatory and Lipid Factors and Total Urinary Polyphenol in Patients With Unstable Angina


Sponsor

Shahid Beheshti University of Medical Sciences

Enrollment

70 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The present study will examine the effects of increasing dietary polyphenol intake by consumption of oregano and basil leaves, on plasma inflammatory and lipid factors and total urinary polyphenol levels in patients who have recently had unstable angina.


Eligibility

Min Age: 30 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Control (Standard treatment) and Higher polyphenol intake by consumption of oregano and basil for people with acute coronary syndromes and unstable angina (ua). The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERControl (Standard treatment)

Patients receive standard medical treatment.

OTHERHigher polyphenol intake by consumption of oregano and basil

Patients consume 4-5 grams of dried oregano and 4-5 grams of dried basil leaves daily for two months in addition to their usual medical treatment.


Locations(1)

Imam Husain hospital

Tehran, Tehran Province, Iran

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07123181


Related Trials